142 related articles for article (PubMed ID: 37158306)
21. Automation and validation of a MALDI-TOF MS (Mass-Fix) replacement of immunofixation electrophoresis in the clinical lab.
Kohlhagen M; Dasari S; Willrich M; Hetrick M; Netzel B; Dispenzieri A; Murray DL
Clin Chem Lab Med; 2020 Aug; 59(1):155-163. PubMed ID: 32745067
[TBL] [Abstract][Full Text] [Related]
22. Diagnostic performance of serum free light chain measurement in patients suspected of a monoclonal B-cell disorder.
Vermeersch P; Van Hoovels L; Delforge M; Mariën G; Bossuyt X
Br J Haematol; 2008 Nov; 143(4):496-502. PubMed ID: 18729849
[TBL] [Abstract][Full Text] [Related]
23. Mass spectrometry for the evaluation of monoclonal proteins in multiple myeloma and related disorders: an International Myeloma Working Group Mass Spectrometry Committee Report.
Murray DL; Puig N; Kristinsson S; Usmani SZ; Dispenzieri A; Bianchi G; Kumar S; Chng WJ; Hajek R; Paiva B; Waage A; Rajkumar SV; Durie B
Blood Cancer J; 2021 Feb; 11(2):24. PubMed ID: 33563895
[TBL] [Abstract][Full Text] [Related]
24. Elucidating heterogeneity of IgA1 hinge-region O-glycosylation by use of MALDI-TOF/TOF mass spectrometry: role of cysteine alkylation during sample processing.
Franc V; Řehulka P; Raus M; Stulík J; Novak J; Renfrow MB; Šebela M
J Proteomics; 2013 Oct; 92():299-312. PubMed ID: 23891555
[TBL] [Abstract][Full Text] [Related]
25. The clinical spectrum of IgM monoclonal gammopathy: A single center retrospective study of 377 patients.
Cao XX; Meng Q; Mao YY; Su W; Zhen JF; Shen KN; Zhang CL; Huang XF; Duan MH; Zhang W; Zhu TN; Cai HC; Chen M; Zhou DB; Li J
Leuk Res; 2016 Jul; 46():85-8. PubMed ID: 27232065
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of Serum Free Light Chain in Diagnosis and Monitoring of Plasma Cell Disorders.
Ansari AA; Tipu HN; Ahmed D; Farhan M
Crit Rev Immunol; 2019; 39(3):203-210. PubMed ID: 32421964
[TBL] [Abstract][Full Text] [Related]
27. Spatial resolution of renal amyloid deposits through MALDI-MSI: a combined digital and molecular approach to monoclonal gammopathies.
Bindi G; Smith A; Oliveira G; Eccher A; Vatrano S; Alberici F; Cazzaniga G; Galimberti S; Capitoli G; Magni F; Pagni F; L'Imperio V
J Clin Pathol; 2024 May; 77(6):402-410. PubMed ID: 36813560
[TBL] [Abstract][Full Text] [Related]
28. Serum and Urine Protein Electrophoresis and Serum-Free Light Chain Assays in the Diagnosis and Monitoring of Monoclonal Gammopathies.
Singh G
J Appl Lab Med; 2020 Nov; 5(6):1358-1371. PubMed ID: 33150391
[TBL] [Abstract][Full Text] [Related]
29. A comparison between high resolution serum protein electrophoresis and screening immunofixation for the detection of monoclonal gammopathies in serum.
Smith J; Raines G; Schneider HG
Clin Chem Lab Med; 2018 Jan; 56(2):256-263. PubMed ID: 28787269
[TBL] [Abstract][Full Text] [Related]
30. [The value of serum free light chain in differential diagnosis of monoclonal gammopathy of renal significance].
Li C; Wen YB; Li H; Su W; Li J; Cai JF; Chen LM; Li XM; Li XW
Zhonghua Yi Xue Za Zhi; 2017 Aug; 97(30):2344-2348. PubMed ID: 28822451
[No Abstract] [Full Text] [Related]
31. The potential role of mass spectrometry for the identification and monitoring of patients with plasma cell disorders: Where are we now and which questions remain unanswered?
Giles HV; Wechalekar A; Pratt G
Br J Haematol; 2022 Aug; 198(4):641-653. PubMed ID: 35514140
[TBL] [Abstract][Full Text] [Related]
32. Quantitation of serum free light chains does not compensate for serum immunofixation only when screening for monoclonal gammopathies.
Böer K; Deufel T
Clin Chem Lab Med; 2009; 47(9):1109-15. PubMed ID: 19728853
[TBL] [Abstract][Full Text] [Related]
33. Comparison of serum immunofixation electrophoresis and free light chain assays in the detection of monoclonal gammopathies.
Wood PB; McElroy YG; Stone MJ
Clin Lymphoma Myeloma Leuk; 2010 Aug; 10(4):278-80. PubMed ID: 20709664
[TBL] [Abstract][Full Text] [Related]
34. The monoclonal gammopathies.
Kyle RA
Clin Chem; 1994 Nov; 40(11 Pt 2):2154-61. PubMed ID: 7955402
[TBL] [Abstract][Full Text] [Related]
35. Improved Screening of Monoclonal Gammopathy Patients by MALDI-TOF Mass Spectrometry.
Pečinka L; Vlachová M; Moráň L; Gregorová J; Porokh V; Kovačovicová P; Almáši M; Pour L; Štork M; Havel J; Ševčíková S; Vaňhara P
J Am Soc Mass Spectrom; 2023 Dec; 34(12):2646-2653. PubMed ID: 37994781
[TBL] [Abstract][Full Text] [Related]
36. Assessment of the analytical performance and the sensitivity of serum free light chains immunoassay in patients with monoclonal gammopathy.
Wolff F; Thiry C; Willems D
Clin Biochem; 2007 Mar; 40(5-6):351-4. PubMed ID: 17239359
[TBL] [Abstract][Full Text] [Related]
37. Monoclonal antibody therapeutics as potential interferences on protein electrophoresis and immunofixation.
Willrich MA; Ladwig PM; Andreguetto BD; Barnidge DR; Murray DL; Katzmann JA; Snyder MR
Clin Chem Lab Med; 2016 Jun; 54(6):1085-93. PubMed ID: 26812875
[TBL] [Abstract][Full Text] [Related]
38. Plasma and serum exosome markers analyzed by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry coupled with electron multiplier.
Shan L; Gao H; Zhang J; Li W; Su Y; Guo Y
Talanta; 2022 Sep; 247():123560. PubMed ID: 35623246
[TBL] [Abstract][Full Text] [Related]
39. Use of MALDI-TOF mass spectrometry fingerprinting to characterize Enterococcus spp. and Escherichia coli isolates.
Santos T; Capelo JL; Santos HM; Oliveira I; Marinho C; Gonçalves A; Araújo JE; Poeta P; Igrejas G
J Proteomics; 2015 Sep; 127(Pt B):321-31. PubMed ID: 25753124
[TBL] [Abstract][Full Text] [Related]
40. Detecting monoclonal immunoglobulins in human serum using mass spectrometry.
Mills JR; Barnidge DR; Murray DL
Methods; 2015 Jun; 81():56-65. PubMed ID: 25916620
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
